Meropenem 500 mg & 1 g Injection
PDF Leaflet Revision Date: 04 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible bacteria.
Dosage (summary)
Adults: 500 mg to 1 g IV every 8 hours; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended in pregnancy; avoid in breastfeeding.
Key Drug Interactions
- Probenecid
- Valproic acid
- Oral anticoagulants
Contraindications
- Hypersensitivity to meropenem
- History of hypersensitivity to beta-lactams
Common side effects
- Nausea
- Diarrhoea
- Headache
- Rash
Counselling Points
- Report any allergic reactions
- Monitor for gastrointestinal symptoms
- Avoid mixing with other medications
Serious warnings
- Serious hypersensitivity reactions
- Seizures
- Antibiotic-associated colitis
Important Disclaimer
The Meropenem 500 mg & 1 g Injection professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
